Antimicrobial PVC Wall Cladding

The World's First Antimicrobial PVC Wall Cladding .

BioClad antimicrobial hygienic wall cladding is a unique product, ideal for almost any environment where a hygienic surface finish is paramount. PVC wall cladding has become an increasingly popular alternative to traditional methods because it offers a range of sophisticated finishes and colours while maintaining its hygienic integrity.

BioClad are continuously developing and improving our range of hygienic wall cladding products and services to provide our customers with the most comprehensive hygienic solutions and the highest standards in design and function.

BioClad PVC wall cladding has silver ions embedded at the time of manufacture, which means that antimicrobial protection is active throughout every sheet and provides 24/7 protection for the lifetime of the product. BioClad antimicrobial wall cladding remains effective even when scratched because our antimicrobial protection cannot be washed away.

The BioClad PVC cladding system is effective at significantly reducing the incidence of bacteria, microbes, protozoans and fungi. This has been proven in both clinical and independent field trials. BioClad panels are now widely used throughout our own National Health Service (NHS)

Utilising Antimicrobial Technology, BioClad will:

  • Inhibit growth of MRSA, E.coli, Legionella, Salmonella and Mould by up to 99.9% PROVEN
  • Continues to control bacteria 24/7
  • Guaranteed protection for expected lifetime of BioClad
  • BioClad will guarantee ADDED VALUE to your hygienic cladding package

BioClad - Applications

BioClad is the world's first proven antimicrobial PVC hygienic wall cladding. Antimicrobial silver ion is impregnated into the hygienic cladding panels at the time of manufacture. This helps stop the growth of bacteria and mould which works continuously for the lifetime of the panels, reducing levels of bacteria such as MRSA, E Coli, Legionella, Salmonella and mould (including Aspergillus Niger) by up to 99.99%.

BioClad has been proven to work in real-world environments. An independent study was undertaken in a UK care home kitchen where 35 surfaces were tested for their bacteria levels. The BioClad hygienic wall cladding registered a 0 level of bacteria. BioClad incorporates silver ion antimicrobial technology. Silver ion technology is a safe, natural antimicrobial that is added at our point of manufacture ensuring it is present throughout our virgin PVC sheets.

Two outpatient units provided the environments for this 18 month pilot study. Unit A was refurbished with BioCote®-treated products including blinds, tiles, door handles, sack holders and light switches and also a number of untreated products. A similar, refurbished outpatient ward containing untreated items (unit B), served as a control. Both outpatient units were similar in terms of volume of people, layout and floor-surface area and were subjected to standard cleaning practice. Both were allowed to function for 12 months before swabbing commenced. Swabs were collected over a five month period from BioCote®-treated and untreated products in both outpatient units. Swabs were processed for total counts of viable bacteria and results expressed as average counts of colony-forming units (CFUs).

CFU counts from BioCote®-treated products in unit A were between 62% and 98% lower than from comparable, untreated products in unit B. The products used in the trial were manufactured from a variety of materials e.g plastics and fabrics. CFU counts from these different materials were also compared. CFU counts from BioCote®-treated materials were between 70% (fabrics) to 99% (laminates) lower than untreated equivalents. CFU counts from BioCote®-treated products in unit A were compared with CFU counts from untreated products in both unit A and unit B. CFU counts on untreated products in unit A were also compared to untreated products in unit B. This three way comparison provides the following results: the average CFU count from any BioCote® treated product was 95.8% lower than that from any untreated product in unit B the average CFU count from any BioCote® treated product was 92.6% lower than that from any untreated product in the same environment (unit A) the average CFU count from any untreated product in unit A was 43.5% lower than that from any untreated product in unit B.